344 related articles for article (PubMed ID: 21628857)
21. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation in natural killer cell lymphoma and leukemia.
Kwong YL
Int J Hematol; 2010 Dec; 92(5):702-7. PubMed ID: 21107769
[TBL] [Abstract][Full Text] [Related]
23. Management of extranodal natural killer/t-cell lymphoma, nasal type.
Chaudhary RK; Bhatt VR; Vose JM
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):245-52. PubMed ID: 25659751
[TBL] [Abstract][Full Text] [Related]
24. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.
Kohrt H; Advani R
Leuk Lymphoma; 2009 Nov; 50(11):1773-84. PubMed ID: 19883307
[TBL] [Abstract][Full Text] [Related]
25. Review on natural killer/T-cell lymphoma.
He X; Gao Y; Li Z; Huang H
Hematol Oncol; 2023 Apr; 41(2):221-229. PubMed ID: 34731509
[TBL] [Abstract][Full Text] [Related]
26. Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management.
Tse E; Fox CP; Glover A; Yoon SE; Kim WS; Kwong YL
Semin Hematol; 2022 Oct; 59(4):198-209. PubMed ID: 36805888
[TBL] [Abstract][Full Text] [Related]
27. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
[TBL] [Abstract][Full Text] [Related]
28. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Jung KS; Cho SH; Kim SJ; Ko YH; Kang ES; Kim WS
J Hematol Oncol; 2016 Apr; 9():41. PubMed ID: 27091029
[TBL] [Abstract][Full Text] [Related]
29. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Liang R
Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
[TBL] [Abstract][Full Text] [Related]
30. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
31. Current management of nasal NK/T-cell lymphoma.
Au WY
Oncology (Williston Park); 2010 Apr; 24(4):352-8. PubMed ID: 20464847
[TBL] [Abstract][Full Text] [Related]
32. Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
Medicine (Baltimore); 2019 Dec; 98(49):e18260. PubMed ID: 31804361
[TBL] [Abstract][Full Text] [Related]
33. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
34. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
35. Esophageal involvement by extranodal natural killer T cell lymphoma, nasal type, mimicking Ebstein Barr viral esophagitis in a tonsillar lymphoma patient undergoing chemoradiation therapy.
Lee SR; Park EK; Won NH; Kim BS
Asia Pac J Clin Oncol; 2010 Sep; 6(3):149-54. PubMed ID: 20887494
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of autologous hematopoietic stem cell transplantation in the treatment of advanced/recurrent nasal type extranodal NK/T-cell lymphoma].
Yuan FF; Yin QS; Fu YW; Wang Q; Chen L; Mi RH; Li YF; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):569-572. PubMed ID: 30122016
[No Abstract] [Full Text] [Related]
37. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
[TBL] [Abstract][Full Text] [Related]
38. NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R
Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
[TBL] [Abstract][Full Text] [Related]
39. Natural killer-cell neoplasms.
Greer JP; Mosse CA
Curr Hematol Malig Rep; 2009 Oct; 4(4):245-52. PubMed ID: 20425414
[TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas.
Takenaka K; Shinagawa K; Maeda Y; Makita M; Kozuka T; Ashiba A; Yamamoto K; Fujii N; Nawa Y; Hiramatsu Y; Sunami K; Ishimaru F; Yoshimo T; Kiura K; Harada M
Leuk Lymphoma; 2001; 42(6):1297-303. PubMed ID: 11911411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
